Skip to main content
    D

    Disc Medicine Inc. (IRON)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $76.59
    -3.41 (-4.26%)

    Market Cap: $3.64B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Disc Medicine Inc. (IRON) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Disc Medicine reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$212.18M, operating cash flow was -$180.39M and free cash flow was -$181.33M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$59.53M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $236.02M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Research and development$170.64M$96.67M$69.26M$33.44M$25.17M$28.17M
    Operating income-$236.02M-$129.72M-$91.13M-$47.48M-$30.93M-$34.04M
    Net income-$212.18M-$109.36M-$76.43M-$46.83M-$35.97M-$40.84M
    EBITDAN/AN/A-$91.03M-$47.45MN/A-$33.73M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0-$19.88M$0$0$0$0$0$0$0$0
    Gross profit$0$0$0-$89.00K$0$0$0-$9.00K$0$0$0-$25.00K
    Operating income-$64.16M-$65.08M-$69.52M-$66.97M-$67.70M-$61.41M-$39.95M-$34.55M-$32.86M-$30.85M-$31.46M-$29.71M
    Net income-$59.53M-$59.53M-$63.50M-$60.53M-$62.32M-$55.25M-$34.09M-$29.46M-$26.60M-$26.35M-$26.95M-$23.58M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $29.77M by $61.38M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$806.88M$496.77M$368.00M$200.21M$92.41M$8.32M
    Current assets$803.90M$493.62M$365.66M$198.49M$90.48M$5.07M
    Cash and equivalents$91.14M$192.43M$360.38M$194.61M$88.04M$4.50M
    Total liabilities$67.05M$53.19M$22.88M$23.61M$14.76M$30.18M
    Short-term debt$611.00K$130.00K$665.00K$307.00K$5.32M$16.69M
    Long-term debt$29.16M$28.32M$0N/A$404.00K$4.95M
    Shareholder equity$739.83M$443.59M$345.12M$176.60M-$64.20M-$21.86M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$699.49M$735.07M$750.21M$806.88M$630.46M$665.06M$709.27M$496.77M$495.14M$510.22M$354.18M$368.00M
    Total liabilities$95.24M$90.91M$61.78M$67.05M$57.06M$50.90M$48.90M$53.19M$27.18M$21.39M$16.11M$22.88M
    Cash and equivalents$89.98M$98.68M$88.91M$91.14M$140.66M$127.34M$122.67M$192.43M$192.64M$280.66M$342.62M$360.38M
    Shareholder equity$604.25M$644.16M$688.43M$739.83M$573.39M$614.16M$660.36M$443.59M$467.96M$488.83M$338.07M$345.12M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$180.39M-$93.93M-$73.46M-$42.25M-$27.53M-$32.71M
    Capital expenditures$933.00K$505.00K$89.00K$151.00K$68.00K$22.00K
    Free cash flow-$181.33M-$94.43M-$73.55M-$42.40M-$27.60M-$32.73M
    Investing cash flow-$394.30M-$292.33M-$89.00K-$151.00K-$68.00K-$22.00K
    Financing cash flow$473.41M$218.31M$239.38M$148.98M$89.93M$34.25M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$40.20M-$44.20M-$62.24M-$43.30M-$47.80M-$47.92M-$41.38M-$27.57M-$17.36M-$15.39M-$33.60M-$17.80M
    Capital expendituresN/AN/A$0$20.00K$26.00K$36.00K$851.00K$449.00K$8.00K$3.00K$67.00K$3.00K
    Free cash flowN/AN/A-$62.24M-$43.32M-$47.83M-$47.95M-$42.23M-$28.02M-$17.37M-$15.40M-$33.67M-$17.80M
    Last 12 quarters

    Frequently Asked Questions About IRON

    What is Disc Medicine's annual revenue?

    Disc Medicine reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Disc Medicine profitable?

    No. Disc Medicine reported net income of -$212.18M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does IRON generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$180.39M minus capital expenditures of $933.00K produced free cash flow of -$181.33M.

    How much debt does Disc Medicine have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $29.16M, short-term debt of $611.00K and cash and equivalents of $91.14M.